206 related articles for article (PubMed ID: 29175018)
1. Understanding serine proteases implications on Leishmania spp lifecycle.
Alves CR; Souza RS; Charret KDS; Côrtes LMC; Sá-Silva MP; Barral-Veloso L; Oliveira LFG; da Silva FS
Exp Parasitol; 2018 Jan; 184():67-81. PubMed ID: 29175018
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a Leishmania donovani serine protease inhibitor: Possible role in regulation of host serine proteases.
Alam MN; Das P; De T; Chakraborti T
Life Sci; 2016 Jan; 144():218-25. PubMed ID: 26656469
[TBL] [Abstract][Full Text] [Related]
3. Effect of different serine protease inhibitors in validating the 115 kDa Leishmania donovani secretory serine protease as chemotherapeutic target.
Chakraborti T; Das P; Choudhury R; De T
Indian J Biochem Biophys; 2015 Feb; 52(1):14-22. PubMed ID: 26040107
[TBL] [Abstract][Full Text] [Related]
4. Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine.
de Matos Guedes HL; Pinheiro RO; Chaves SP; De-Simone SG; Rossi-Bergmann B
Vaccine; 2010 Jul; 28(33):5491-6. PubMed ID: 20472030
[TBL] [Abstract][Full Text] [Related]
5. Leishmanicidal therapy targeted to parasite proteases.
Machado PA; Carneiro MPD; Sousa-Batista AJ; Lopes FJP; Lima APCA; Chaves SP; Sodero ACR; de Matos Guedes HL
Life Sci; 2019 Feb; 219():163-181. PubMed ID: 30641084
[TBL] [Abstract][Full Text] [Related]
6. Serine protease activities in Leishmania (Leishmania) chagasi promastigotes.
da Silva-López RE; dos Santos TR; Morgado-Díaz JA; Tanaka MN; de Simone SG
Parasitol Res; 2010 Oct; 107(5):1151-62. PubMed ID: 20668879
[TBL] [Abstract][Full Text] [Related]
7. Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes.
Silva-Lopez RE; Morgado-Díaz JA; Chávez MA; Giovanni-De-Simone S
Parasitol Res; 2007 Nov; 101(6):1627-35. PubMed ID: 17726617
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-leishmanial efficacy of potato tuber extract (PTEx): leishmanial serine protease(s) as putative target.
Paik D; Das P; De T; Chakraborti T
Exp Parasitol; 2014 Nov; 146():11-9. PubMed ID: 25128800
[TBL] [Abstract][Full Text] [Related]
9. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
[TBL] [Abstract][Full Text] [Related]
10. Natural proteinaceous inhibitors of serine proteases.
Debowski D
Curr Pharm Des; 2013; 19(6):1068-84. PubMed ID: 23016680
[TBL] [Abstract][Full Text] [Related]
11. A general strategy to inhibit serine protease by targeting its autolysis loop.
Jiang L; Yuan C; Huang M
FASEB J; 2021 Feb; 35(2):e21259. PubMed ID: 33417271
[TBL] [Abstract][Full Text] [Related]
12. A critical review on marine serine protease and its inhibitors: A new wave of drugs?
Barzkar N; Khan Z; Tamadoni Jahromi S; Pourmozaffar S; Gozari M; Nahavandi R
Int J Biol Macromol; 2021 Feb; 170():674-687. PubMed ID: 33387547
[TBL] [Abstract][Full Text] [Related]
13. Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease Inhibitors.
Köcher S; Rey J; Bongard J; Tiaden AN; Meltzer M; Richards PJ; Ehrmann M; Kaiser M
Angew Chem Int Ed Engl; 2017 Jul; 56(29):8555-8558. PubMed ID: 28514117
[TBL] [Abstract][Full Text] [Related]
14. Functional attribution of LdISP, an endogenous serine protease inhibitor from Leishmania donovani in promoting infection.
Alam MN; Chakraborti S; Paik D; Bagchi A; Chakraborti T
Biochimie; 2018 Apr; 147():105-113. PubMed ID: 29366936
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization and characterization of two novel proteases in Leishmania donovani: putative roles in host invasion and parasite development.
Choudhury R; Das P; De T; Chakraborti T
Biochimie; 2010 Oct; 92(10):1274-86. PubMed ID: 20595064
[TBL] [Abstract][Full Text] [Related]
16. Ahp cyclodepsipeptides: the impact of the Ahp residue on the "canonical inhibition" of S1 serine proteases.
Stolze SC; Meltzer M; Ehrmann M; Kaiser M
Chembiochem; 2013 Jul; 14(11):1301-8. PubMed ID: 23794257
[TBL] [Abstract][Full Text] [Related]
17. Serine proteases of parasitic helminths.
Yang Y; Wen Yj; Cai YN; Vallée I; Boireau P; Liu MY; Cheng SP
Korean J Parasitol; 2015 Feb; 53(1):1-11. PubMed ID: 25748703
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors in potential drug development for Leishmaniasis.
Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
[TBL] [Abstract][Full Text] [Related]
19. A serine protease from a detergent-soluble extract of Leishmania (Leishmania) amazonensis.
da Silva Lopez RE; De Simone SG
Z Naturforsch C J Biosci; 2004; 59(7-8):590-8. PubMed ID: 15813385
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the serine proteases of the complement system.
Gál P; Dobó J; Beinrohr L; Pál G; Závodszky P
Adv Exp Med Biol; 2013; 735():23-40. PubMed ID: 23402017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
